Rephonic
Artwork for Oncology Today

Oncology Today with Dr Neil Love

Dr. Neil Love
Immunotherapy
Chronic Lymphocytic Leukemia
Ovarian Cancer
Prostate Cancer
Colorectal Cancer
PARP Inhibitors
Clinical Trials
Circulating Tumor DNA
Endometrial Cancer
Diffuse Large B-Cell Lymphoma
Multiple Myeloma
Gastroesophageal Cancer
BTK Inhibitors
Urothelial Bladder Cancer
Pembrolizumab
Venetoclax
Antibody-Drug Conjugates
Non-Hodgkin Lymphoma
Bispecific Antibodies
Breast Cancer

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

PublishesDailyEpisodes541Founded7 years ago
Number of ListenersCategories
ScienceHealth & FitnessMedicine

Listen to this Podcast

Artwork for Oncology Today

Latest Episodes

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

• Case: A woman in her early 70s with endometrioid carcinoma of the ov... more

YouTube

Featuring perspectives from Dr Nicoletta Colombo, Dr Gottfried E Konecny, Dr Alexander B Olawaiye and Dr Shannon N Westin, moderated by Dr Westin, including the following topics:

• Case: A woman in her late 60s with a germline BRCA2 mutation and hea... more

YouTube

Featuring an interview with Prof Karim Fizazi, including the following topics:

• Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00)

• Mechanism of act... more

YouTube

Featuring perspectives from Prof Susana Banerjee, including the following topics:

• Case: A woman in her mid 50s with multiregimen-recurrent low-grade serous ovarian cancer and a KRAS G12V mutation who receives avutometinib/defactinib with response,... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Julia Rotow
Thoracic medical oncologist presenting clinical evidence on bispecific antibodies in lung cancer
NFR Cancer Institute
Episode: Non-Small Cell Lung Cancer — A Presentation by Dr Julia Rotow on the Potential Role of PD-1 x VEGF Bispecific Antibodies
Catherine Coombs
Medical oncologist at UCI Health specializing in chronic lymphocytic leukemia
UCI Health
Episode: Chronic Lymphocytic Leukemia — Microlearning Activity 2
Ursula Matulonis
Clinical investigator at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Nicoletta Colombo
Clinical investigator at the European Institute of Oncology IRCCS
European Institute of Oncology IRCCS
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Alexander Olawaiye
Clinical investigator at the University of Pittsburgh School of Medicine
University of Pittsburgh School of Medicine
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Gottfried Konecny
Clinical investigator at the David Geffen School of Medicine at UCLA
David Geffen School of Medicine at UCLA
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Shannon Westin
Gynecologic oncologist at MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: Ovarian Cancer — Microlearning Activity 2: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Bob Orlowski
Director of Translational Research for Multiple Myeloma at MD Anderson
MD Anderson Cancer Center
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting
Noopur Raje
Director of the Center for Multiple Myeloma and Plasma Cell Disorders at Massachusetts General Brigham Cancer Institute
Massachusetts General Brigham Cancer Institute
Episode: Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2026 Annual Meeting

Host

Neil Love
Host of the program; multiple instances across Oncology Today series

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#213
Saudi Arabia/Science
Apple Podcasts
#214
South Korea/Science

Talking Points

Recent interactions between the hosts and their guests.

Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Q: What do you think, you know, regarding the data with maintenance lurbinectedin in this space, is this now the standard of care? Would you give it with durva?
Liu considers maintenance lurbinectedin a standard approach after induction for extensive-stage small cell lung cancer when tolerated, citing improvements in progression-free and overall survival. He recommends explaining the plan early and starting treatment promptly after induction rather than waiting for progression.
Lung Cancer — Proceedings from a Symposium Held in Conjunction with the American Oncology Network
Q: How do you think through a patient, who would you choose which regimen for?
Liu favors combination treatment for many patients with classical EGFR mutations, comparing osimertinib plus chemotherapy with amivantamab and lazertinib. Kidney function, baseline MET alterations, toxicity profiles, and patient preferences can guide the choice; some patients may choose a TKI alone.
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies
Q: What are some of the other toxicities that are seen with the bispecifics, particularly cytopenias, infections? How do you prophylact against infections, and what about vaccinations?
Budde describes early cytopenias and increased infection risk from prolonged B-cell depletion and low immunoglobulins. She discusses antiviral and PJP prophylaxis, seasonal vaccinations, and IVIG for patients with low IgG or recurrent infections.
Diffuse Large B-Cell Lymphoma — An Interview with Dr L Elizabeth Budde on Employing CD20 x CD3 Bispecific Antibodies
Q: And how would you indirectly compare the risk of CRS with these four agents?
Budde says mosunetuzumab has the lowest cytokine release syndrome risk among the four agents she discusses and describes it as a community-friendly option, while noting its approval status for DLBCL differs from the other agents.
HER2-Positive Gynecologic Cancers — Microlearning Activity 3: Proceedings from an Independent Satellite Symposium during the SGO Annual Meeting on Women's Cancer
Q: What has been your experience using trastuzumab deruxtecan in patients with underlying cardiac disease, and after she progressed through T-DXd, what treatment would you have given her?
The panel considered whether to continue treatment with a dose reduction when cardiac function declines, weighing the patient's response against safety. They also discussed sequencing ADCs based on their targets, payloads and the cancer's biology.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology Today

What is Oncology Today about and what kind of topics does it cover?

A clinically oriented show featuring medical oncologists and cancer researchers discussing new research, treatment strategies, and practical applications for general oncology practice. Episodes commonly center on hematologic and solid tumor malignancies, with deep dives into frontline versus relapse options, sequencing of therapies, adverse event management, and emerging modalities such as MRD-guided decisions, fixed-duration regimens, and novel agents (including BTK inhibitors, venetoclax-based regimens, HER2-targeted therapies, and cell/immune-based approaches). Guests frequently come from major academic centers and cancer institutes, bringing case-based perspectives, trial context, and real-world considerations to help practicing oncolog... more

Where can I find podcast stats for Oncology Today?

Rephonic provides a wide range of podcast stats for Oncology Today. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology Today and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology Today get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Oncology Today, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology Today?

Rephonic provides comprehensive predictive audience data for Oncology Today, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology Today have?

To see how many followers or subscribers Oncology Today has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology Today?

These podcasts share a similar audience with Oncology Today:

1. Two Onc Docs
2. Research To Practice | Oncology Videos
3. Oncology Brothers: Practice-Changing Cancer Discussions
4. OncLive® On Air
5. Breast Cancer Update

How many episodes of Oncology Today are there?

Oncology Today launched 7 years ago and published 541 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology Today?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology Today?

Rephonic pulls ratings and reviews for Oncology Today from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology Today?

Rephonic provides full transcripts for episodes of Oncology Today. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology Today?

Recent guests on Oncology Today include:

1. Julia Rotow
2. Catherine Coombs
3. Ursula Matulonis
4. Nicoletta Colombo
5. Alexander Olawaiye
6. Gottfried Konecny
7. Shannon Westin
8. Bob Orlowski

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days